Share on LinkedInShare on LinkedIn

ARTICLE · 23 JULY 2014

A Culture Shift? Pre-Certification Summary Trial In Product Liability Case

McCarthy Tétrault
McCarthy Tétrault
Contributor
McCarthy Tétrault

McCarthy Tétrault

McCarthy Tétrault LLP provides a broad range of legal services, delivering strategic and...

View firm profile
Explore more from McCarthy Tétrault

The BC Supreme Court released a decision in Player v. Janssen-Ortho Inc., a proposed product liability class action involving transdermal fentanyl patches.

CanadaLitigation, Mediation & Arbitration

On June 20, 2014, the BC Supreme Court released a decision in Player v. Janssen-Ortho Inc.,1 a proposed product liability class action involving transdermal fentanyl patches. The Court dismissed the action against two of the five defendants in a summary trial prior to certification.

The case is significant in three ways:

  1. Scope of inquiry:  The Court held that while in other provinces pre-certification class proceedings are treated as "any old [individual] action", in BC, proposed class actions are treated as "action[s] with ambition". In this context, the Court concluded that evidence relating to the proposed class—and not just the individual plaintiff—could be considered on a pre-certification summary trial application, despite that any judgment would bind only the plaintiff.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from